Inventor · disambiguated record
Frederic J. De Sauvage
Also filed as: DE SAUVAGE FREDERIC J · DE SAUVAGE FREDERIC JOSEPH · DE SAUVAGE Frederic
45 granted patents·43 pending applications·291 citations·filing 1994–2023
98Inventor score
Top patents by PatentIndex Score
88 records- 0193US7303896B2Nucleic acid encoding novel type-1 cytokine receptor GLM-RGENENTECH INC·Filed 2003·Granted Dec 4, 2007·38 cites·15 claims
- 0290US7858330B2Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2006·Granted Dec 28, 2010·15 cites·20 claims
- 0389US7888478B2Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2005·Granted Feb 15, 2011·15 cites·92 claims
- 0488US7691973B2GFRα3 polypeptidesGENENTECH INC·Filed 2006·Granted Apr 6, 2010·7 cites·11 claims
- 0586US9085630B2Compositions and methods for the treatment of tumor of hematopoietic originCROWLEY CRAIG·Filed 2011·Granted Jul 21, 2015·10 cites·39 claims
- 0686US7931902B2Gene disruptions, compositions and methods relating theretoGENENTECH INC·Filed 2006·Granted Apr 26, 2011·11 cites·3 claims
- 0786US7754441B2Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2006·Granted Jul 13, 2010·10 cites·11 claims
- 0885US8388973B2Compositions and methods for the treatment of tumor of hematopoietic originCHANG WESLEY·Filed 2010·Granted Mar 5, 2013·7 cites·58 claims
- 0985US7285382B2Compositions and methods for treatment of cancerGENENTECH INC·Filed 2001·Granted Oct 23, 2007·17 cites·3 claims
- 1084US7691566B2Compositions and methods for treatment of cancerGENENTECH INC·Filed 2006·Granted Apr 6, 2010·5 cites·6 claims
- 1184US7625759B2Method for using BOC/CDO to modulate hedgehog signalingGENENTECH INC·Filed 2007·Granted Dec 1, 2009·5 cites·8 claims
- 1283US7393532B1Modulation of T cell differentiation for the treatment of T helper cell mediated diseasesGENENTECH INC·Filed 2000·Granted Jul 1, 2008·13 cites·9 claims
- 1383US6022708AFusedGENENTECH INC·Filed 1998·Granted Feb 8, 2000·53 cites·25 claims
- 1481US8481680B2Mutant smoothened and methods of using the sameDE SAUVAGE FREDERIC J·Filed 2011·Granted Jul 9, 2013·4 cites·3 claims
- 1581US6492139B1Vertebrate smoothened proteinsGENENTECH INC·Filed 2000·Granted Dec 10, 2002·5 cites·28 claims
- 1677US9096686B2E518A/K mutant smoothened and methods of using the sameGENENTECH INC·Filed 2013·Granted Aug 4, 2015·3 cites·5 claims
- 1776US7858843B2Gene disruptions, compositions and methods relating theretoGENENTECH INC·Filed 2006·Granted Dec 28, 2010·4 cites·3 claims
- 1873US8435754B2Method of diagnosing the presence of a tumor in a mammal by assessing CDO expression levelsDE SAUVAGE FREDERIC J·Filed 2011·Granted May 7, 2013·1 cites·10 claims
- 1971US7144996B1Nucleic acid encoding human suppressor of fusedGENENTECH INC·Filed 2000·Granted Dec 5, 2006·1 cites·19 claims
- 2069US6136958AAntibodies to vertebrate smoothened proteinsGENENTECH INC·Filed 1997·Granted Oct 24, 2000·16 cites·13 claims
- 2167US7026138B1Polynucleotides encoding GFRα3GENENTECH INC·Filed 1999·Granted Apr 11, 2006·16 cites·5 claims
- 2266US2021338778A1Methods for treatment of microbial disordersGENENTECH INC·Filed 2021·Application pending·0 cites
- 2366US2024101708A1Multispecific Binding Protein Degrader Platform and Methods of UseGENENTECH INC·Filed 2023·Application pending·0 cites
- 2465US2010098624A1Method for using cdo antagonists to modulate hedgehog signalingGENENTECH INC·Filed 2009·Application pending·0 cites
- 2564US2020199208A1Anti rspo antibodies and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 2664US2011097325A1Modulation of T cell Differentiation for the treatment of T helper cell mediated diseasesGENENTECH INC·Filed 2009·Application pending·0 cites
- 2762US7811777B2Methods of screening for agonists and antagonists of patched-2GENENTECH INC·Filed 2006·Granted Oct 12, 2010·0 cites·13 claims
- 2862US2005238650A1Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2004·Application pending·0 cites
- 2962US2009068178A1Compositions and Methods for the Treatment of Tumor of Hematopoietic OriginGENENTECH INC·Filed 2008·Application pending·0 cites
- 3061US7259245B2Anti-fused antibodiesGENENTECH INC·Filed 2002·Granted Aug 21, 2007·0 cites·37 claims
- 3161US2009202475A1Compositions and methods for treatment of microbial disordersGENENTECH INC·Filed 2008·Application pending·0 cites
- 3257US2007134238A1Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated DiseasesGENENTECH INC·Filed 2006·Application pending·0 cites
- 3357US2015147333A1Anti-rspo antibodies and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 3457US2006216289A1GFRalpha3 and its usesDE SAUVAGE FREDERIC J·Filed 2006·Application pending·0 cites
- 3556US8394939B2Nucleic acid encoding fusedDE SAUVAGE Frederic·Filed 2006·Granted Mar 12, 2013·0 cites·16 claims
- 3656US2002156245A1Patched-2 antibodiesGENENTECH INC·Filed 2001·Application pending·0 cites
- 3756US2017362318A1Compositions and methods for the treatment of tumor hematopoietic originGENENTECH INC·Filed 2017·Application pending·0 cites
- 3855US7579161B2Assay methods for suppressor of fused modulation of hedgehog signalingGENENTECH INC·Filed 2005·Granted Aug 25, 2009·0 cites·11 claims
- 3954US7649082B2Persephin specific antibodiesUNIV WASHINGTON·Filed 2005·Granted Jan 19, 2010·0 cites·2 claims
- 4054US6451977B1Fused polypeptidesGENENTECH INC·Filed 1999·Granted Sep 17, 2002·7 cites·19 claims
- 4154US2005226869A1Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2004·Application pending·0 cites
- 4254US2005221330A1GFRalpha3 and its usesDE SAUVAGE FREDERIC J·Filed 2003·Application pending·0 cites
- 4353US2018312579A1Anti rspo antibodies and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 4453US2009053226A1Compositions and methods for the treatment of tumor of hematopoietic originCROWLEY CRAIG·Filed 2008·Application pending·0 cites
- 4552US5830647AHybridization and amplification of nucleic acids encoding mpl ligandGENENTECH INC·Filed 1995·Granted Nov 3, 1998·13 cites·4 claims
- 4652US2007136829A1Novel type-1 cytokine receptor glm-rGHILARDI NICO P·Filed 2006·Application pending·0 cites
- 4751US2013052159A1Methods for treatment of microbial disordersABBAS ALEXANDER R·Filed 2012·Application pending·0 cites
- 4851US2009142348A1Novel Gene Disruptions, Compositions and Methods Relating TheretoGENENTECH INC·Filed 2007·Application pending·0 cites
- 4950US2010249034A1Gfralpha3 and its usesDE SAUVAGE FREDERIC J·Filed 2010·Application pending·0 cites
- 5050US2009293137A1Novel Gene Disruptions, Compositions and Methods Relating TheretoGENENTECH INC·Filed 2006·Application pending·0 cites
Showing the top 50 of 88 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →